CANON MEDICAL RESEARCH EUROPE, LIMITED
Get an alert when CANON MEDICAL RESEARCH EUROPE, LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£9.7m
+5.3% highest in 3 filed years
Net assets
£12m
+7.2% highest in 3 filed years
Employees
121
-9% lowest in 3 filed years
Profit before tax
£4m
-13.3% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
Although the Company expects a reduction in funding levels during 2026 following the reprioritisation of development programmes within the Canon group... discussions remain ongoing regarding the future balance between NRE-funded development activity and technology licensing income... the Company's ultimate parent undertaking, Canon Inc., has provided a letter of support confirming its intention to provide such financial assistance as may be necessary to enable the Company to continue in operational existence for a period of at least 12 months from the date of approval of these financial statements.
-
Going-concern uncertainty disclosed
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £16,878,000 | £17,781,000 | £15,944,000 | -10.3% | |
| Operating profit | £4,000,000 | £4,515,000 | £3,897,000 | -13.7% | |
| Profit before tax | £4,031,000 | £4,587,000 | £3,976,000 | -13.3% | |
| Net profit | £3,030,000 | £3,375,000 | £2,971,000 | -12% | |
| Cash | £7,854,000 | £9,258,000 | £9,749,000 | +5.3% | |
| Total assets less current liabilities | £9,355,000 | £10,760,000 | £11,653,000 | +8.3% | |
| Net assets | £9,355,000 | £10,760,000 | £11,537,000 | +7.2% | |
| Equity | £9,355,000 | £10,760,000 | £11,537,000 | +7.2% | |
| Average employees | 135 | 133 | 121 | -9% | |
| Wages | £8,514,000 | £8,841,000 | £8,834,000 | -0.1% | |
| Directors' remuneration | £408,000 | £418,000 | £490,000 | +17.2% | |
| Directors' pension contributions | £28,000 | £30,000 | £37,000 | +23.3% | |
| Highest paid director | £249,000 | £259,000 | £263,000 | +1.5% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 23.7% | 25.4% | 24.4% | |
| Net margin | 18.0% | 19.0% | 18.6% | |
| Return on capital employed | 42.8% | 42.0% | 33.4% | |
| Gearing (liabilities / total assets) | 16.1% | 15.0% | 21.4% | |
| Current ratio | 6.15x | 6.63x | 4.78x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation
- CANON MEDICAL RESEARCH EUROPE, LIMITED 2018-01-04 → present
- TOSHIBA MEDICAL VISUALIZATION SYSTEMS EUROPE, LIMITED 2008-11-12 → 2018-01-04
- TOSHIBA MEDICAL VISUALIZATION SYSTEMS LIMITED 2008-09-03 → 2008-11-12
- DUNWILCO (1555) LIMITED 2008-04-22 → 2008-09-03
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“Although the Company expects a reduction in funding levels during 2026 following the reprioritisation of development programmes within the Canon group... discussions remain ongoing regarding the future balance between NRE-funded development activity and technology licensing income... the Company's ultimate parent undertaking, Canon Inc., has provided a letter of support confirming its intention to provide such financial assistance as may be necessary to enable the Company to continue in operational existence for a period of at least 12 months from the date of approval of these financial statements.”
Significant events
- “On 1 April 2026, Canon Medical Systems Corporation was integrated into Canon Inc. meaning Canon Inc. became the immediate parent company from this date.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
8 active · 25 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| SUTHARSHAN, Jamuna | Secretary | 2026-01-01 | — | — |
| ANDERSON, Jannine Mary | Director | 2026-01-01 | Jun 1979 | British |
| DONOHOE, Mark | Director | 2025-08-01 | Oct 1972 | British |
| KOGA, Akihiro | Director | 2022-03-28 | Sep 1967 | Japanese |
| MATSUMOTO, Kazuto | Director | 2026-04-01 | Mar 1970 | Japanese |
| SMOUT, Andrew, Dr | Director | 2019-10-01 | Apr 1963 | British |
| SUTHERLAND, Ken Gavin Neil, Dr | Director | 2013-04-15 | Jun 1967 | British |
| TAKADA, Yoichi | Director | 2022-03-28 | Oct 1966 | Japanese |
Show 25 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DONOHOE, Mark | Secretary | 2022-01-14 | 2026-01-01 |
| FRIEDBERG, Fredric | Secretary | 2008-10-10 | 2017-04-01 |
| HYDE, Peter | Secretary | 2017-04-20 | 2022-01-14 |
| D.W. COMPANY SERVICES LIMITED | Corporate Secretary | 2008-04-22 | 2008-10-10 |
| AOYAMA, Hiroshi | Director | 2008-11-19 | 2010-06-24 |
| ASAHINA, Hiroshi | Director | 2008-11-19 | 2010-12-16 |
| FRIEDBERG, Fredric | Director | 2008-10-10 | 2017-04-01 |
| IKEDA, Satoshi | Director | 2020-01-01 | 2021-06-01 |
| KAMIJIMA, Chikao | Director | 2008-11-19 | 2014-07-01 |
| KOMATSU, Kenichi, Dr | Director | 2008-11-19 | 2010-06-24 |
| KURA, Hiroyuki | Director | 2011-04-23 | 2016-07-01 |
| LAWRIE, Colin Thomas | Director | 2008-09-30 | 2008-10-10 |
| NAKAZATO, Toshiaki | Director | 2008-11-19 | 2009-05-14 |
| NOBUTA, Yasuo | Director | 2016-07-01 | 2019-10-01 |
| SAKAMITSU, Yoshiyuki | Director | 2014-07-01 | 2022-09-12 |
| SASAKI, Naoki | Director | 2016-07-01 | 2022-03-28 |
| SHIMONO, Yoshinori | Director | 2022-09-12 | 2026-04-01 |
| SUGIHARA, Naoki | Director | 2020-04-01 | 2022-03-28 |
| TACHIKAWA, Hiroyuki | Director | 2014-07-01 | 2016-07-01 |
| TACHIZAKI, Hisashi | Director | 2016-07-01 | 2018-07-20 |
| TAKADA, Yoichi | Director | 2018-07-20 | 2020-04-01 |
| TANAKA, Keiji | Director | 2010-06-24 | 2014-07-01 |
| TSUNAKAWA, Satoshi | Director | 2010-06-24 | 2013-04-10 |
| D.W. COMPANY SERVICES LIMITED | Corporate Director | 2008-09-30 | 2008-11-19 |
| D.W. DIRECTOR 1 LIMITED | Corporate Director | 2008-04-22 | 2008-11-19 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr Ken Gavin Neil Sutherland | Individual | Significant influence | 2016-05-01 | Active |
Filing timeline
Last 20 of 119 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-10 | AA | accounts | Accounts with accounts type full | |
| 2026-07-01 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-07-01 | TM01 | officers | Termination director company with name termination date | |
| 2026-07-01 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-07-01 | TM01 | officers | Termination director company with name termination date | |
| 2026-04-27 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-04-14 | TM01 | officers | Termination director company with name termination date | |
| 2026-04-14 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-20 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-15 | TM02 | officers | Termination secretary company with name termination date | |
| 2026-01-13 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-11-20 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-08 | AA | accounts | Accounts with accounts type full | |
| 2025-01-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-26 | AAMD | accounts | Accounts amended with accounts type full | |
| 2024-07-18 | AA | accounts | Accounts with accounts type full | |
| 2024-01-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-19 | AA | accounts | Accounts with accounts type full | |
| 2023-01-09 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 13
- Capital events
- 0
- Officers appointed
- 3
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.